- Home
- ESPR vs LFMD Comparison
ESPR vs LFMD Comparison
Compare ESPR & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- LFMD
- Stock Information
- Founded
- ESPR 2008
- LFMD 1994
- Country
- ESPR United States
- LFMD United States
- Employees
- ESPR N/A
- LFMD N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- LFMD Medical/Nursing Services
- Sector
- ESPR Health Care
- LFMD Health Care
- Exchange
- ESPR Nasdaq
- LFMD Nasdaq
- Market Cap
- ESPR 305.0M
- LFMD 306.7M
- IPO Year
- ESPR 2013
- LFMD N/A
- Fundamental
- Price
- ESPR $1.69
- LFMD $5.60
- Analyst Decision
- ESPR Buy
- LFMD Strong Buy
- Analyst Count
- ESPR 7
- LFMD 7
- Target Price
- ESPR $6.36
- LFMD $11.57
- AVG Volume (30 Days)
- ESPR 4.2M
- LFMD 2.0M
- Earning Date
- ESPR 03-04-2025
- LFMD 03-10-2025
- Dividend Yield
- ESPR N/A
- LFMD N/A
- EPS Growth
- ESPR N/A
- LFMD N/A
- EPS
- ESPR N/A
- LFMD N/A
- Revenue
- ESPR $332,314,000.00
- LFMD $212,453,838.00
- Revenue This Year
- ESPR $5.51
- LFMD $23.50
- Revenue Next Year
- ESPR $1.42
- LFMD $17.20
- P/E Ratio
- ESPR N/A
- LFMD N/A
- Revenue Growth
- ESPR 185.66
- LFMD 39.27
- 52 Week Low
- ESPR $1.47
- LFMD $3.99
- 52 Week High
- ESPR $3.94
- LFMD $12.88
- Technical
- Relative Strength Index (RSI)
- ESPR 49.78
- LFMD 49.82
- Support Level
- ESPR $1.47
- LFMD $5.47
- Resistance Level
- ESPR $1.61
- LFMD $6.03
- Average True Range (ATR)
- ESPR 0.12
- LFMD 0.48
- MACD
- ESPR 0.02
- LFMD 0.07
- Stochastic Oscillator
- ESPR 56.41
- LFMD 62.03
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.